Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model.

Corrigendum to “Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia” [Int. Immunopharmacol. 44 (2017) 38-42].

Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia.